Call Us Now

+91 9606900005 / 04

For Enquiry

legacyiasacademy@gmail.com

INDIA EYES GLOBAL FRONT RUNNERS: COVID VACCINE

Focus: GS-III Science and Technology, Prelims  

Why in news?

Covid-19 vaccines being developed by UK’s Oxford-AstraZeneca and United States’s Moderna-NIAID are the top candidates India is looking at for possible acquisition discussions.

Details

  • India is at present waiting for trial data for the Russian candidate, which became the first coronavirus vaccine to be approved in the world.
  • For now, India is looking at the Oxford-AstraZeneca vaccine, which is in co-production with Serum Institute of India for the Indian market, the Moderna vaccine, which has also entered phase 3 trails and nine other vaccine development programmes — including ones in Germany and Israel.

-Source: Hindustan Times

Download PDF
October 2022
MTWTFSS
 12
3456789
10111213141516
17181920212223
24252627282930
31 
Categories